A recombinant rabies virus expressing the Marburg virus glycoprotein is dependent upon ADCC for protection against Marburg virus disease in a murine model
R Keshwara, KR Hagen, T Abreu-Mota, AB Papaneri… - 2019 - repositorium.uminho.pt
Marburg virus (MARV) is a filovirus related to Ebola virus (EBOV) associated with human
hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality …
hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality …
A recombinant rabies virus expressing the Marburg virus glycoprotein is dependent upon antibody-mediated cellular cytotoxicity for protection against Marburg virus …
R Keshwara, KR Hagen, T Abreu-Mota… - Journal of …, 2019 - Am Soc Microbiol
Marburg virus (MARV) is a filovirus related to Ebola virus (EBOV) associated with human
hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality …
hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality …
A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized …
J Bi, H Wang, Q Han, H Pei, H Wang, H Jin… - Emerging Microbes & …, 2023 - Taylor & Francis
Marburg virus disease (MVD) is a lethal viral haemorrhagic fever caused by Marburg virus
(MARV) with a case fatality rate as high as 88%. There is currently no vaccine or antiviral …
(MARV) with a case fatality rate as high as 88%. There is currently no vaccine or antiviral …
De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses
D Wang, AL Schmaljohn, NU Raja, CM Trubey… - Vaccine, 2006 - Elsevier
Marburg virus (MARV) is an African filovirus that causes a deadly hemorrhagic fever in
humans, with up to 90% mortality. Currently, there are no MARV vaccines or therapies …
humans, with up to 90% mortality. Currently, there are no MARV vaccines or therapies …
Preclinical development of inactivated rabies virus–based polyvalent vaccine against rabies and filoviruses
M Willet, D Kurup, A Papaneri, C Wirblich… - The Journal of …, 2015 - academic.oup.com
We previously described the generation of a novel Ebola virus (EBOV) vaccine based on
inactivated rabies virus (RABV) containing EBOV glycoprotein (GP) incorporated in the …
inactivated rabies virus (RABV) containing EBOV glycoprotein (GP) incorporated in the …
[HTML][HTML] Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges
D Wang, M Hevey, LY Juompan, CM Trubey, NU Raja… - Virology, 2006 - Elsevier
The Marburg virus (MARV), an African filovirus closely related to the Ebola virus, causes a
deadly hemorrhagic fever in humans, with up to 90% mortality. Currently, treatment of …
deadly hemorrhagic fever in humans, with up to 90% mortality. Currently, treatment of …
Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus
Infections with Marburg virus (MARV) and Ebola virus (EBOV) cause severe hemorrhagic
fever in humans and nonhuman primates (NHPs) with fatality rates up to 90%. A number of …
fever in humans and nonhuman primates (NHPs) with fatality rates up to 90%. A number of …
Single-shot ChAd3-MARV vaccine in modified formulation buffer shows 100% protection of NHPs
CL Finch, TH King, KJ Alfson, KA Albanese, JNP Smith… - Vaccines, 2022 - mdpi.com
Marburg virus (MARV) is a virus of high human consequence with a case fatality rate of 24–
88%. The global health and national security risks posed by Marburg virus disease (MVD) …
88%. The global health and national security risks posed by Marburg virus disease (MVD) …
Macaque antibodies targeting Marburg virus glycoprotein induced by multivalent immunization
BM Janus, R Wang, TE Cleveland IV… - Journal of …, 2024 - Am Soc Microbiol
Marburg virus infection in humans is associated with case fatality rates that can reach up to
90%, but to date, there are no approved vaccines or monoclonal antibody (mAb) …
90%, but to date, there are no approved vaccines or monoclonal antibody (mAb) …
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
R Hunegnaw, AN Honko, L Wang, D Carr… - Science translational …, 2022 - science.org
Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality
rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent …
rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent …